• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化腹水患者的管理:最新证据和争议。

Management of ascites in patients with liver cirrhosis: recent evidence and controversies.

机构信息

Division of Gastroenterology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.

出版信息

J Chin Med Assoc. 2013 Mar;76(3):123-30. doi: 10.1016/j.jcma.2012.11.005. Epub 2013 Jan 23.

DOI:10.1016/j.jcma.2012.11.005
PMID:23497963
Abstract

Ascites formation in patients with cirrhosis, portal hypertension, or both usually results from hyperdynamic circulatory dysfunction, where the retention of sodium and water is associated with the activation of the sympathetic and renin-angiotensin-aldosterone systems. The presence of ascites indicates the development of liver decompensation. Furthermore, complications seen in conjunction with ascites such as spontaneous bacterial peritonitis, hepatorenal syndrome, and hepatic hydrothorax may result in increased morbidity and mortality. Although nonpharmacological, pharmacological, and surgical approaches have been introduced and clinically practiced, their therapeutic effects are still suboptimal or limited by their potential side effects, such as large-volume paracentesis-induced postparacentesis circulatory dysfunction. Herein, we discuss strategies to prevent and properly manage ascites-related complications, including a review of the literature and controlled studies that assess these strategies.

摘要

肝硬化、门静脉高压或两者并存的患者腹水的形成通常是由于高动力循环功能障碍所致,钠和水的潴留与交感神经和肾素-血管紧张素-醛固酮系统的激活有关。腹水的出现表明肝功能失代偿的发生。此外,与腹水相关的并发症,如自发性细菌性腹膜炎、肝肾综合征和肝性胸水,可能导致发病率和死亡率增加。尽管已经引入并在临床上应用了非药物、药物和手术方法,但它们的治疗效果仍然不理想,或者受到其潜在副作用的限制,例如大量腹腔穿刺术引起的腹腔穿刺后循环功能障碍。在此,我们讨论预防和妥善处理腹水相关并发症的策略,包括对这些策略进行评估的文献综述和对照研究。

相似文献

1
Management of ascites in patients with liver cirrhosis: recent evidence and controversies.肝硬化腹水患者的管理:最新证据和争议。
J Chin Med Assoc. 2013 Mar;76(3):123-30. doi: 10.1016/j.jcma.2012.11.005. Epub 2013 Jan 23.
2
Management of ascites and hepatorenal syndrome.腹水和肝肾综合征的管理。
Hepatol Int. 2018 Feb;12(Suppl 1):122-134. doi: 10.1007/s12072-017-9815-0. Epub 2017 Aug 23.
3
Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem.肝硬化的并发症。II. 肾脏与循环功能障碍。一个重要临床问题中的光明与阴影
J Hepatol. 2000;32(1 Suppl):157-70. doi: 10.1016/s0168-8278(00)80423-7.
4
[Hepatorenal syndrome: diagnosis, treatment and prevention].[肝肾综合征:诊断、治疗与预防]
Ugeskr Laeger. 2013 May 27;175(22):1562-6.
5
Diagnosis and therapy of ascites in liver cirrhosis.肝硬化腹水的诊断与治疗。
World J Gastroenterol. 2011 Mar 14;17(10):1237-48. doi: 10.3748/wjg.v17.i10.1237.
6
[Physiopathology of refractory ascites and the hepatorenal syndrome].[顽固性腹水和肝肾综合征的病理生理学]
Nefrologia. 2002;22 Suppl 5:41-6.
7
Albumin May Prevent the Morbidity of Paracentesis-Induced Circulatory Dysfunction in Cirrhosis and Refractory Ascites: A Pilot Study.白蛋白可能预防肝硬化和顽固性腹水患者腹腔穿刺术诱发的循环功能障碍的发病:一项初步研究。
Dig Dis Sci. 2016 Oct;61(10):3084-3092. doi: 10.1007/s10620-016-4140-3. Epub 2016 Apr 5.
8
EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.欧洲肝脏研究学会肝硬化腹水、自发性细菌性腹膜炎和肝肾综合征管理临床实践指南
J Hepatol. 2010 Sep;53(3):397-417. doi: 10.1016/j.jhep.2010.05.004. Epub 2010 Jun 1.
9
Management of ascites in cirrhosis.肝硬化腹水的管理
Clin Liver Dis. 2005 Nov;9(4):715-32, viii. doi: 10.1016/j.cld.2005.07.008.
10
Minimizing ascites. Complication of cirrhosis signals clinical deterioration.尽量减少腹水。肝硬化并发症预示着临床病情恶化。
Postgrad Med. 2001 Feb;109(2):91-6, 101-3. doi: 10.3810/pgm.2001.02.854.

引用本文的文献

1
A Novel Scoring System for Assessing In-Hospital Mortality Risk in Patients With Liver Cirrhosis.一种用于评估肝硬化患者院内死亡风险的新型评分系统。
Cureus. 2024 Nov 1;16(11):e72823. doi: 10.7759/cureus.72823. eCollection 2024 Nov.
2
Scoring system for predicting 90-day mortality of in-hospital liver cirrhosis patients at Cipto Mangunkusumo Hospital.预测 Cipto Mangunkusumo 医院住院肝硬化患者 90 天死亡率的评分系统。
BMC Gastroenterol. 2023 Jun 1;23(1):190. doi: 10.1186/s12876-023-02813-4.
3
Causes of Death and Survival in Alcoholic Cirrhosis Patients Undergoing Liver Transplantation: Influence of the Patient's Clinical Variables and Transplant Outcome Complications.
接受肝移植的酒精性肝硬化患者的死亡原因及生存率:患者临床变量和移植结果并发症的影响
Diagnostics (Basel). 2021 May 27;11(6):968. doi: 10.3390/diagnostics11060968.
4
Pretransplant ascites and encephalopathy and their influence on survival and liver graft rejection in alcoholic cirrhosis disease.移植前腹水和肝性脑病及其对酒精性肝硬化疾病患者生存和肝移植排斥反应的影响。
Arch Med Sci. 2019 Jun 18;17(3):682-693. doi: 10.5114/aoms.2018.80651. eCollection 2021.
5
Xiaozhang Tie Improves Intestinal Motility in Rats With Cirrhotic Ascites by Regulating the Stem Cell Factor/c-kit Pathway in Interstitial Cells of Cajal.小张铁通过调节 Cajal 间质细胞中的干细胞因子/c-kit 通路改善肝硬化腹水大鼠的肠道动力。
Front Pharmacol. 2020 Feb 4;11:1. doi: 10.3389/fphar.2020.00001. eCollection 2020.
6
Glucobrassicin Metabolites Ameliorate the Development of Portal Hypertension and Cirrhosis in Bile Duct-Ligated Rats.硫代葡萄糖苷代谢产物可改善胆管结扎大鼠门静脉高压和肝硬化的发展。
Int J Mol Sci. 2019 Aug 26;20(17):4161. doi: 10.3390/ijms20174161.
7
Spontaneous bacterial and fungal peritonitis in patients with liver cirrhosis: A literature review.肝硬化患者的自发性细菌性和真菌性腹膜炎:文献综述
World J Hepatol. 2018 Feb 27;10(2):254-266. doi: 10.4254/wjh.v10.i2.254.
8
Vascular invasion in hepatitis B virus-related hepatocellular carcinoma with underlying cirrhosis: possible associations with ascites and hepatitis B viral factors?伴有潜在肝硬化的乙型肝炎病毒相关肝细胞癌中的血管侵犯:与腹水及乙型肝炎病毒因素的可能关联?
Tumour Biol. 2015 Aug;36(8):6255-63. doi: 10.1007/s13277-015-3311-8. Epub 2015 Apr 2.
9
Paracentesis-induced circulatory dysfunction: a primer for the interventional radiologist.腹腔穿刺术引起的循环功能障碍:介入放射科医生入门指南。
Semin Intervent Radiol. 2014 Sep;31(3):276-8. doi: 10.1055/s-0034-1382799.
10
Health-related quality of life and survival in Chinese patients with chronic liver disease.中国慢性肝病患者的健康相关生活质量和生存情况。
Health Qual Life Outcomes. 2013 Aug 1;11:131. doi: 10.1186/1477-7525-11-131.